Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Human prion protein sequence elements impede cross-species chronic wasting disease transmission.

The Journal of clinical investigation

Kurt TD, Jiang L, Fernández-Borges N, Bett C, Liu J, Yang T, Spraker TR, Castilla J, Eisenberg D, Kong Q, Sigurdson CJ.
PMID: 25961458
J Clin Invest. 2015 Jun;125(6):2548. doi: 10.1172/JCI82647. Epub 2015 May 11.

No abstract available.

Cite
Kurt TD, Jiang L, Fernández-Borges N, et al. Human prion protein sequence elements impede cross-species chronic wasting disease transmission. J Clin Invest. 2015;125(6):2548doi: 10.1172/JCI82647.
Kurt, T. D., Jiang, L., Fernández-Borges, N., Bett, C., Liu, J., Yang, T., Spraker, T. R., Castilla, J., Eisenberg, D., Kong, Q., & Sigurdson, C. J. (2015). Human prion protein sequence elements impede cross-species chronic wasting disease transmission. The Journal of clinical investigation, 125(6), 2548. https://doi.org/10.1172/JCI82647
Kurt, Timothy D, et al. "Human prion protein sequence elements impede cross-species chronic wasting disease transmission." The Journal of clinical investigation vol. 125,6 (2015): 2548. doi: https://doi.org/10.1172/JCI82647
Kurt TD, Jiang L, Fernández-Borges N, Bett C, Liu J, Yang T, Spraker TR, Castilla J, Eisenberg D, Kong Q, Sigurdson CJ. Human prion protein sequence elements impede cross-species chronic wasting disease transmission. J Clin Invest. 2015 Jun;125(6):2548. doi: 10.1172/JCI82647. Epub 2015 May 11. PMID: 25961458; PMCID: PMC4497774.
Copy Download .nbib Format: NLM
Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines.

Pathobiology of aging & age related diseases

Keene CD, Darvas M, Kraemer B, Liggitt D, Sigurdson C, Ladiges W.
PMID: 27317189
Pathobiol Aging Age Relat Dis. 2016 Jun 16;6:32397. doi: 10.3402/pba.v6.32397. eCollection 2016.

Dozens of transgenic mouse models, generally based on mutations associated with familial Alzheimer's disease (AD), have been developed, in part, for preclinical testing of candidate AD therapies. However, none of these models has successfully predicted the clinical efficacy of...

Cite
Keene CD, Darvas M, Kraemer B, et al. Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines. Pathobiol Aging Age Relat Dis. 2016;6:32397doi: 10.3402/pba.v6.32397.
Keene, C. D., Darvas, M., Kraemer, B., Liggitt, D., Sigurdson, C., & Ladiges, W. (2016). Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines. Pathobiology of aging & age related diseases, 632397. https://doi.org/10.3402/pba.v6.32397
Keene, C Dirk, et al. "Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines." Pathobiology of aging & age related diseases vol. 6 (2016): 32397. doi: https://doi.org/10.3402/pba.v6.32397
Keene CD, Darvas M, Kraemer B, Liggitt D, Sigurdson C, Ladiges W. Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines. Pathobiol Aging Age Relat Dis. 2016 Jun 16;6:32397. doi: 10.3402/pba.v6.32397. eCollection 2016. PMID: 27317189; PMCID: PMC4912600.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries